Hologic, Inc. (NASDAQ:HOLX) will be discussing 4Q20 financial results with the investment community.on 4th November 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.hologic.com
Earnings Expectation
Hologic, Inc. is set to announce fourth quarter earning results on Wednesday 4th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, HOLX to report 4Q20 income of $ 1.22 per share. For the full year, analysts anticipate top line of $ 3531.96 million, while looking forward to income of $ 3.12 per share bottom line.
The Company Outlook
Earnings for 4Q20 are anticipated in a range of $ 0.95 ~ $ 1.15 per share, while revenues are expected in a range of $ 1,225.00 million ~ $ 1,275.00 million
Full Year 2020 topline are forecasted in a range of$ 3,238.00 million ~ $ 3,268.00 million, where as bottomline are predicted in a range of $ 2.63 ~ $ 2.67 per share
Click Here For More Historical Outlooks Of Hologic, Inc.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. The company offers Aptima molecular diagnostic assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products.
